Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma
出版年份 2016 全文链接
标题
Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma
作者
关键词
Resveratrol, STAT3/5, PTPε, SHP-2, Renal cell carcinoma
出版物
BMC Nephrology
Volume 17, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-02-25
DOI
10.1186/s12882-016-0233-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Farnesol inhibits tumor growth and enhances the anticancer effects of bortezomib in multiple myeloma xenograft mouse model through the modulation of STAT3 signaling pathway
- (2015) Jong Hyun Lee et al. CANCER LETTERS
- Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel
- (2015) Jong Hyun Lee et al. Oncotarget
- 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways
- (2015) Sung-Moo Kim et al. MOLECULAR CARCINOGENESIS
- Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model
- (2014) Muthu K. Shanmugam et al. MOLECULAR CARCINOGENESIS
- Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
- (2013) Aruljothi Subramaniam et al. BRITISH JOURNAL OF PHARMACOLOGY
- Celastrol Suppresses Growth and Induces Apoptosis of Human Hepatocellular Carcinoma through the Modulation of STAT3/JAK2 Signaling Cascade In Vitro and In Vivo
- (2012) P. Rajendran et al. Cancer Prevention Research
- Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics
- (2012) W. M. Linehan GENOME RESEARCH
- Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target
- (2012) Hua Wang et al. International Journal of Biological Sciences
- Ultrasonic-Assisted Extraction of the Botanical Dietary Supplement Resveratrol and Other Constituents of Polygonum cuspidatum
- (2012) Bao-Yuan Chen et al. JOURNAL OF NATURAL PRODUCTS
- Resveratrol and cellular mechanisms of cancer prevention
- (2011) Yogeshwer Shukla et al. Annals of the New York Academy of Sciences
- Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN
- (2011) Ji Young Heo et al. CANCER LETTERS
- Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells
- (2010) Sun-Hee Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness
- (2009) J S Thompson Coon et al. BRITISH JOURNAL OF CANCER
- Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
- (2009) V Bilim et al. BRITISH JOURNAL OF CANCER
- Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma
- (2009) Naomi Walsh et al. BMC Urology
- Guggulsterone, a Farnesoid X Receptor Antagonist, Inhibits Constitutive and Inducible STAT3 Activation through Induction of a Protein Tyrosine Phosphatase SHP-1
- (2008) K. S. Ahn et al. CANCER RESEARCH
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
- (2008) David J. Newman JOURNAL OF MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started